Roşca EV - Search Results

1

New 2-(4-(4-bromophenylsulfonyl)phenyl)-4-arylidene-oxazol-5(4H)-ones: analgesic activity and histopathological assessment.

Bărbuceanu F, Roşca EV, Apostol TV, Şeremet OC, Drăghici C, Mihai DP, Negreş S, Niţulescu GM, Bărbuceanu ŞF. Bărbuceanu F, et al. Among authors: rosca ev. Rom J Morphol Embryol. 2020 Apr-Jun;61(2):493-502. doi: 10.47162/RJME.61.2.19. Rom J Morphol Embryol. 2020. PMID: 33544801 Free PMC article.

2

New Heterocyclic Compounds from Oxazol-5(4H)-one and 1,2,4-Triazin-6(5H)-one Classes: Synthesis, Characterization and Toxicity Evaluation.

Barbuceanu SF, Rosca EV, Apostol TV, Socea LI, Draghici C, Farcasanu IC, Ruta LL, Nitulescu GM, Iscrulescu L, Pahontu EM, Boscencu R, Saramet G, Olaru OT. Barbuceanu SF, et al. Among authors: rosca ev. Molecules. 2023 Jun 17;28(12):4834. doi: 10.3390/molecules28124834. Molecules. 2023. PMID: 37375389 Free PMC article.

3

Hydrophobin-Encapsulated Quantum Dots.

Taniguchi S, Sandiford L, Cooper M, Rosca EV, Ahmad Khanbeigi R, Fairclough SM, Thanou M, Dailey LA, Wohlleben W, von Vacano B, de Rosales RT, Dobson PJ, Owen DM, Green M. Taniguchi S, et al. Among authors: rosca ev. ACS Appl Mater Interfaces. 2016 Feb;8(7):4887-93. doi: 10.1021/acsami.5b11354. Epub 2016 Feb 10. ACS Appl Mater Interfaces. 2016. PMID: 26824334

4

Thermosensitive, near-infrared-labeled nanoparticles for topotecan delivery to tumors.

Rosca EV, Wright M, Gonitel R, Gedroyc W, Miller AD, Thanou M. Rosca EV, et al. Mol Pharm. 2015 May 4;12(5):1335-46. doi: 10.1021/mp5002679. Epub 2015 Apr 20. Mol Pharm. 2015. PMID: 25826624

5

PET/PDT theranostics: synthesis and biological evaluation of a peptide-targeted gallium porphyrin.

Bryden F, Savoie H, Rosca EV, Boyle RW. Bryden F, et al. Among authors: rosca ev. Dalton Trans. 2015 Mar 21;44(11):4925-32. doi: 10.1039/c4dt02949f. Dalton Trans. 2015. PMID: 25437884 Free article.

6

A biomimetic collagen derived peptide exhibits anti-angiogenic activity in triple negative breast cancer.

Rosca EV, Penet MF, Mori N, Koskimaki JE, Lee E, Pandey NB, Bhujwalla ZM, Popel AS. Rosca EV, et al. PLoS One. 2014 Nov 10;9(11):e111901. doi: 10.1371/journal.pone.0111901. eCollection 2014. PLoS One. 2014. PMID: 25384034 Free PMC article.

7

Biosynthesis of luminescent quantum dots in an earthworm.

Stürzenbaum SR, Höckner M, Panneerselvam A, Levitt J, Bouillard JS, Taniguchi S, Dailey LA, Ahmad Khanbeigi R, Rosca EV, Thanou M, Suhling K, Zayats AV, Green M. Stürzenbaum SR, et al. Among authors: rosca ev. Nat Nanotechnol. 2013 Jan;8(1):57-60. doi: 10.1038/nnano.2012.232. Epub 2012 Dec 23. Nat Nanotechnol. 2013. PMID: 23263722

8

Synergy between a collagen IV mimetic peptide and a somatotropin-domain derived peptide as angiogenesis and lymphangiogenesis inhibitors.

Koskimaki JE, Lee E, Chen W, Rivera CG, Rosca EV, Pandey NB, Popel AS. Koskimaki JE, et al. Among authors: rosca ev. Angiogenesis. 2013 Jan;16(1):159-70. doi: 10.1007/s10456-012-9308-7. Epub 2012 Sep 29. Angiogenesis. 2013. PMID: 23053781 Free PMC article.

9

Serpin-derived peptides are antiangiogenic and suppress breast tumor xenograft growth.

Koskimaki JE, Rosca EV, Rivera CG, Lee E, Chen W, Pandey NB, Popel AS. Koskimaki JE, et al. Among authors: rosca ev. Transl Oncol. 2012 Apr;5(2):92-7. doi: 10.1593/tlo.11244. Epub 2012 Apr 1. Transl Oncol. 2012. PMID: 22496925 Free PMC article.

10

Collagen IV and CXC chemokine-derived antiangiogenic peptides suppress glioma xenograft growth.

Rosca EV, Lal B, Koskimaki JE, Popel AS, Laterra J. Rosca EV, et al. Anticancer Drugs. 2012 Aug;23(7):706-12. doi: 10.1097/CAD.0b013e3283531041. Anticancer Drugs. 2012. PMID: 22495619 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

19 results

Search Page